Interaction of the antitumour antibiotic streptonigrin with DNA and oligonucleotides

Anti-Cancer Drug Design

Volumn 12, Issue 6, 1997, Pages 453-472

  Long, Georgina V ^a   Harding, Margaret M ^a   Fan, Jun Yao ^b   Denny, William A ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antitumor antibiotic; DNA cleavage; Drug oligonucleotide complex; Footprinting; Streptonigrin

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; COPPER ION; MANGANESE; METAL ION; OLIGONUCLEOTIDE; PLASMID DNA; RUFOCROMOMYCIN; ZINC;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA CLEAVAGE; DNA FOOTPRINTING; DNA SEQUENCE; DNA SUPERCOILING; DRUG DNA INTERACTION; ENANTIOMER; GEL ELECTROPHORESIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CATTLE; CIRCULAR DICHROISM; DNA; DNA FOOTPRINTING; ELECTROPHORESIS, AGAR GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MAGNETIC RESONANCE SPECTROSCOPY; OLIGONUCLEOTIDES; SPECTROPHOTOMETRY, ULTRAVIOLET; STREPTONIGRIN;

EID: 8544236988     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. BACHUR, N.R., GORDON, S L. & GEE, M.V. (1978). A general mechanism for the microsomal activation of quinone anticancer agents to free radicals. Cancer Research, 38, 1745.
2. BACHUR, N R., GORDON, S L , GEE, M V & KON, H. (1979). NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proceedings of the National Academy of Sciences, USA, 76, 954.
3. 3 with small DNA duplexes. Binding to GC-containing sequences. Biochemistry 29, 6521.
4. BARTON, J.K , DANNENBERG, JJ & RAPHAEL, A.L (1982). Enantiomeric selectivity in binding tris(phenanthroline)zinc(II) to DNA. Journal of the American Chemical Society, 104, 4967.
5. BARTON, JK , DANISHEFSKY, A T. & GOLDBERG, JM (1984). Tris(phenanthroline)ruthenium(II): stereoselectivity in binding to DNA. Journal of the American Chemical Society, 106, 2172.
6. BAX, A. & DAVIS, D.G. (1985). MLEV-17-Based two-dimensional homonuclear magnetization transfer spectroscopy. Journal of Magnetic Resonance, 65, 355.
7. BOGER, D.L , YASUDA, M , MITSCHER, L A , DRAKE, S.D., KITOS, P.A. & COLLINS THOMPSON, S. (1987). Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones. Journal of Medicinal Chemistry, 30, 1918.
8. BRAUNSCHWEILER, L & ERNST, R.R. (1983). Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. Journal of Magnetic Resonance, 53, 521.
9. CAPRANICO, G., PALUMBO, M., TINELLI, S. & ZUNINO, F (1994). Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin. Journal of Biological Chemistry, 269, 25004.
10. CHIRIGOS, M A., PEARSON, J.W., PAPAS, TS, WOODS, WA , WOOD, H.B JR & SPAHN, G (1973). Effect of Streptonigrin (NSC-45383) and analogs of oncornavirus replication and DNA polymerase activity. Cancer Chemotherapy Reports, 57, 305.
11. CONE, R., HASAN, S.K , LOWN, J W & MORGAN, A.R. (1976). The mechanism of the degradation of DNA by streptonigrin. Canadian Journal of Biochemistry, 54, 219.
12. DHOLAKIA, S. & GILLARD, R.D. (1981). Chsroptical properties of streptonigrin and a comment on atropisomerism in heterocyclic compounds. Tetrahedron, 37, 2929.
13. FEIGON, J, DENNY, WA, LEUPIN, W. & KEARNS, D.R. (1984). Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics. Journal of Medicinal Chemistry, 27, 450.
14. FIALLO, M.M.L. & GARNIER-SUILLEROT, A. (1990). Interaction of the antitumor drug streptonigrin with palladium(II) ions. Evidence of the formation of a superoxo-palladium(II)-streptonigrin complex. Inorganic Chemistry, 29, 893.
15. 31P-NMR lines in a short DNA duplex with homo- and heteronuclear correlated spectroscopy. Biopolymers 24, 2371.
16. 1H NMR study. Acta Chemica Scandinavica, 45, 219.
17. FROYSTEIN, N.A , DAVIS, J.T., REID, B.R. & SLETTEN. E (1993). Sequence-selective metal ion binding to DNA oligonucleotides. Acta Chemica Scandinavica, 47, 649.
18. GLASOE, PK & LONG, F.A. (1960). Use of glass electrodes to measure acidities in deuterium oxide. Journal of Physical Chemistry, 64, 188.
19. 2 and with plasmid pBR322 support intercalative association with the B-DNA helix. Biochemistry, 28, 726.
20. 31P NMR. Chemical Reviews, 94, 1315.
21. 2 adduct from one- and two-dimensional proton NMR experiments in solution. Biochemistry, 24, 7573.
22. GUTTERIDGE, J.M. (1984). Streptonigrin-induced deoxyribose degradation: inhibition by superoxide dismutase, hydroxyl radical scavengers and iron chelators. Biochemical Pharmacology, 33, 3059.
23. HACKERTHAL, C A., GOLBEY, R.B , TAN, C.T.C., KARNOFSKY, D.A. & BURCHENAL, J.H. (1961). Clinical Observations on the effects of streptonigrin in patients with neoplastic disease. Antibiotic Chemotherapy, 11, 178.
24. HAJDU, J. (1985) Interaction of metal ions with streptonigrin and biological properties of the complexes. Metal Ions in Biological Systems, 19, 53.
25. HAJDU, J & ARMSTRONG, E.C. (1981) Interaction of metal ions with streptonigrin. 1. Formation of copper(II) and zinc(II) complexes of the antitumor antibiotic. Journal of the American Chemical Society, 103, 232.
26. HARDING, M.M., LONG, G.V. & BROWN, C L. (1993). Solution structure of the antitumor drug streptonigrin. Journal of Medicinal Chemistry, 36, 3056.
27. HARLEY, J.B, FETTEROLF, C.J., BELLO, C.A. & FLAKS, J.G. (1982). Streptonigrin toxicity in Escherichia coli: oxygen dependence and the role of the intracellular oxidation-reduction state. Canadian Journal of Microbiology, 28, 545.
28. HASSETT, D.J., BRITIGAN, B.E., SVENDSEN, T., ROSEN, G M, & COHEN, M S (1987). Bacteria form intracellular free radicals in response to paraquat and streptonigrin. Demonstration of the potency of hydroxyl radical. Journal of Biological Chemistry, 262, 13404.
29. HORE, PJ. (1983). Solvent suppression in Fourier transform nuclear magnetic resonance. Journal of Magnetic Resonance, 55, 283.
30. JEENER, J, MEIER, B.H , BACHMANN, P. & ERNST, R R. (1979). Investigation of exchange processes by two-dimensional NMR spectroscopy. Journal of Chemical Physics, 71, 4546.
31. 13C NMR spectroscopy. Inorganic Chemistry, 30, 228.
32. KUMAR, A., ERNST, R.R & WÜTHRICH. K. (1980). A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochemical and Biophysical Research Communications, 95, 1.
33. LETEURTRE, F., KOHLHAGEN, G. & POMMIER, Y. (1994). Streptonigrin-induced topoisomerase II sites exhibit base preferences in the middle of the enzyme stagger. Biochemical and Biophysical Research Communications, 203, 1259.
34. 1H NMR study of the interaction of zinc(II) with the antitumor drug streptonigrin. Journal of the Chemical Society Dalton Transactions, 549.
35. LONG, G.V., HARDING, M.M., TURNER, P. & HAMBLEY, T.W. (1995a). Copper(II) bipyridyl and aminopyridyl analogues of streptonigrin. Journal of the Chemical Society Dalton Transactions, 3905.
36. LONG, G.V., HARDING, M.M., XIE, M.C L., TURNER, P. &. HAMBLEY, T.W. (1995b). 3-Amino-6,6′-dimethoxycarbonyl-2,2′-bipyridine dimethylester, a model for the central chelation unit of streptonigrin. Journal of the Chemical Society Dalton Transactions, 951.
37. MCBRIDE, T.J., OLESON, J.J. & WOOLF, D. (1966). The activity of streptonigrin against the Rauscher murine leukemia virus in vivo. Cancer Research, 26A, 727.
38. MCCRAKEN, S. & ABOODY, A. (1965) Continuous intravenous infusion of streptonigrin (NSC-45383) in patients with bronchogenic carcinoma. Cancer Chemotherapy Reports, 46, 23.
39. 2 by 2D-NMR correlation spectroscopy. Biochemical and Biophysical Research Communications, 124, 774.
40. 1H spin-spin coupling constants in proteins. Biochemical and Biophysical Research Communications, 113, 967.
41. MOHAMIDI, F , RICHARDS, N.G.J., GUIDA, WC., LISKAMP, R , LIPTON, M., CAUFIELD. C., CHANG, G. HENDIKSON, T. & STILL, W.C. (1990). MacroModel - an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. Journal of Computational Chemistry, 11, 440.
42. MOUSTATIH, A. & GARNIER-SUILLEROT, A. (1989). Bifunctional antitumor compounds: synthesis and characterisation of a Au(III)-streptonigrin complex with thiol-modulating properties. Journal of Medicinal Chemistry, 32, 1426.
43. NATRAJAN, A & HECHT, S. (1994). In Neidle, S. & Waring, M. J. (eds), Molecular Aspects of Anticancer Drug-DNA Action. Macmillan, London, p. 197.
44. PIANTINI, U., SORENSON, O. & ERNST, R.R (1982). Multiple quantum filters for elucidating NMR coupling networks. Journal of the American Chemical Society, 104, 6800.
45. PLATEAU, P. & GUERON, M. (1982). Exchangeable proton NMR without base-line distortion, using new strong-pulse sequences. Journal of the American Chemical Society, 104, 7310.
46. RAO, K V. (1977) Streptonigrin and related compounds. III. synthesis and microbiological activity of destrioxyphenylstreptonigrin and analogues. Journal of Heterocyclic Chemistry, 14, 653.
47. RAO, K.V. (1979). Interaction of streptonigrin with metals and with DNA. Journal of Pharmaceutical Science, 68, 853.
48. SEARLE, M.S., HALL, J.G , DENNY, W.A. & WAKELIN, L.P.G (1988). NMR studies of the interaction of the antibiotic nogalamycin with the hexadeoxyribonucleotide duplex d(5′-GCATGC)2. Biochemistry, 27, 4340.
49. 2+ in complexes in solution. Quantification of equilibria involving a change of the coordination number of the metal ion. Chemical Society Reviews, 83.
50. SINHA, B.K. (1981). Irreversible binding of reductively activated streptonigrin to nucleic acids in the presence of metals. Chemical and Biological Interactions, 36, 179.
51. SUGIURA, Y, KUAHARA, J. & SUZUKI, T. (1984). DNA interaction and nucleotide sequence cleavage of copper-streptonigrin. Biochimica et Biophysica Acta, 782, 254.
52. SULLIVAN, R D., MILLER, E, ZUREK, W. & RODRIGUEZ, FR (1963). Clincal effects of prolonged (continuous) infusion of streptonigrin (NSC-45383) in advanced cancer. Cancer Chemotherapy Reports, 33, 27.
53. TAKESHITA, M , GROLLMAN, A.P, OHTSUBO, E & OHTSUBO, H (1978). Interaction of blcomycin with DNA. Proceedings of the National Academy of Sciences, USA, 75, 5983.
54. TENNANT, S. (1992).PhD Thesis, Australian National University.
55. VON HOFF, D D, ROZENCWEIG, M., SOPER, W.T., HELLMAN, L.J., PENTA, J.S., DAVIS. H.L & MUGGIA, F.M (1977) Whatever happened to NSC? Cancer Treatment Reports, 61, 759.
56. WHITE. J.R. & DEARMAN, H.H. (1965). Generation of free radicals from phenazine methosulphate, streptonigrin, and rubiflavin in bacterial suspensions. Proceedings of the National Academy of Sciences, USA, 54, 887.
57. WHITE, H.L. & WHITE, J.R. (1968). Lethal action and metabolic effects of streptonigrin on Escherichia coli. Molecular Pharmacology, 4, 549.
58. WHITE, J R. (1977). Streptonigrin-transition metal complexes: binding to DNA and biological activity. Biochemical and Biophysical Research Communications, 77, 387.
59. WHITE, J.R & YEOWELL, H N (1982). Iron enhances the bactericidal action of streptonigrin. Biochemical and Biophysical Research Communications, 106, 407.
60. 31P NMR chemical shift and relaxation investigation. Nucleic Acids Research, 10, 1399.
61. WILSON, W.L., LABRA, C. & BARRIST, E. (1961). Preliminary observations on the use of streptonigrin as an antitumour agent in human beings. Antibiotic Chemotherapy, 11, 147.
62. YAMASHITA, Y., KAWADA, S, FUII, N. & NAKANO, H. (1990). Induction of mammalian DNA topoisomerase II dependent DNA cleavage by antitumor antibiotic streptonigrin. Cancer Research, 50, 5841.